These articles cover a wide range of subjects, from the most basic aspects of diabetes care to the nitty-gritty specifics.

Links not loading properly?

Some of our pages use Portable Document Format (PDF) files, which require Adobe Acrobat Reader. To download Acrobat Reader for free, visit www.adobe.com.

Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.



 

Learn more
Sample e-newsletter

Learn more about diabetes

Links to help you learn more about diabetes.

Ask a diabetes expert
Other diabetes resources
Browse article topics


Print |
Text Size:
A

A

A

1     2     3     4     5     Show All    

Updated October 29, 2007

Exenatide and Pramlintide
New Meds on the Block

by Stacy Griffin, Pharm.D., and John Borders, M.D.

The most commonly reported side effects of sitagliptin were stuffy or runny nose and sore throat, headache, diarrhea, and joint pain. The most common side effect of vildagliptin is hypoglycemia if a person has missed a meal or exercised strenuously. Fluid retention has occurred with vildagliptin in some people, but nausea has not been reported. Neither sitagliptin nor vildagliptin has been associated with weight gain. People who have taken vildagliptin while participating in research studies have experienced an average decrease in HbA1c of 0.6%. Large studies will help in evaluating the long-term safety information of DPP-IV inhibition.

Changing with the times
In 2004, despite the availability of numerous options for treating diabetes, studies showed that only 33% of people with Type 2 diabetes were meeting established targets for blood glucose control. Optimal blood glucose control is important to prevent or minimize the chronic complications that can be caused by diabetes, including nerve, kidney, eye, and heart disease.

If you are unable to keep your blood glucose levels in target range with your current diabetes plan, talk to your diabetes care team about other available treatment options, including those newly on the market. Work together with your team to achieve the best possible blood glucose control for you.

1     2     3     4     5     Show All    

Stacy Griffin is a diabetes educator for Drs. Borders & Associates, PSC, an American Diabetes Association-recognized education service in Lexington, Kentucky, and John Borders is a practicing internist at Drs. Borders & Associates, PSC. Dr. Griffin is also a pharmacist at Central Baptist Hospital, also in Lexington, Kentucky.

More articles on Insulin

Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information provided on this Web site should not be construed as medical instruction. Consult appropriate health-care professionals before taking action based on this information.

We also recommend

Symlin Now Available in a Pen

The injected diabetes drug pramlintide (brand name Symlin) is now available in pen... Blog Entry

Byetta and Pancreatitis: What You Should Know

The U.S. Food and Drug Administration (FDA) announced on August 18 that six cases... Blog Entry

Generic Drugs

All drugs—whether prescription or over the counter—have a nonproprietary name (also... Article

In the current Diabetes Self-Management November/December 2008 Issue Diabetes Self-Management November/December 2008 Issue

New Tools 2008

Read up on the latest meters, pumps, and other tools for managing diabetes.

Making Exercise More Fun

This article suggests strategies to change your attitude toward exercise.

Quiz: How Much Do You Know About Athlete’s Foot?

This common fungal disease can happen to anyone, not just athletes.

Complete table of contents
Get a FREE ISSUE
Subscription questions

With Meals and Menus you can whip up delicious, healthy meals every day!